The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The utility of cyclodextrins for enhancing oral bioavailability
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive supramolecular chemistry
(1997) · Choice Reviews Online · doi:10.5860/choice.34-5097 · Cited by 6,476
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
The Stability of Cyclodextrin Complexes in Solution
Connors, K. A. (1997) · Chemical Reviews · doi:10.1021/cr960371r · Cited by 2,175
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Szejtli, J. (1988) · Topics in Inclusion Science · doi:10.1007/978-94-015-7797-7 · Cited by 1,759
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Cyclodextrins in drug delivery: An updated review
Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060243 · Cited by 1,215
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Cyclodextrin-based controlled drug release system
Hirayama, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00058-1 · Cited by 494
Mechanisms of drug release from cyclodextrin complexes
Stella, V. J., Rao, V. M., Zannou, E. A., & Zia, V. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00052-0 · Cited by 442
CyclodextrinsEnabling Excipients: Their Present and Future Use in Pharmaceuticals
Thompson, D. O. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i1.10 · Cited by 421
Design and Evaluation of Cyclodextrin-Based Drug Formulation
Uekama, K. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.900 · Cited by 356
Medicinal Applications of Cyclodextrins
Szejtli, J. (1994) · Medicinal Research Reviews · doi:10.1002/med.2610140304 · Cited by 347
Yu, L. X., Lipka, E., Crison, J. R., & Amidon, G. L. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00009-9 · Cited by 335
Cyclodextrins in drug carrier systems.
Uekama, K., & Otagiri, M. (1987) · PubMed · Cited by 300
Role of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
The effect of water-soluble polymers on drug-cyclodextrin complexation
Loftsson, T., Frikdriksdóttir, H., Sigurkdardóttir, A. M., & Ueda, H. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90155-4 · Cited by 192
Population Characteristics of Cyclodextrin Complex Stabilities in Aqueous Solution
Connors, K. A. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840712 · Cited by 188
Kostewicz, E. S., Brauns, U., Becker, R., & Dressman, J. B. (2002) · Pharmaceutical Research · doi:10.1023/a:1014407421366 · Cited by 180
Cyclodextrins and carrier systems
Duchêne, D., Wouessidjewe, D., & Ponchel, G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00046-2 · Cited by 159
Drug/Cyclodextrin/Hydroxy Acid Multicomponent Systems. Properties and Pharmaceutical Applications
Redenti, E., Szente, L., & Szejtli, J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<1::aid-jps1>3.0.co;2-w · Cited by 154
Zia, V., Rajewski, R. A., & Stella, V. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011041628797 · Cited by 149
Arima, H., Yunomae, K., Miyake, K., Irie, T., Hirayama, F., & Uekama, K. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1025 · Cited by 134
Miyake, K., Arima, H., Hirayama, F., Yamamoto, M., Horikawa, T., Sumiyoshi, H., Noda, S., & Uekama, K. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100100556 · Cited by 120
Wong, J. W., & Yuen, K. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00796-7 · Cited by 112
Proceedings of the Fourth International Symposium on Cyclodextrins
Huber, O., & Szejtli, J. (1988) · Springer eBooks · doi:10.1007/978-94-009-2637-0 · Cited by 109
Improving the Dissolution and Bioavailability of Nifedipine Using Solid Dispersions and Solubilizers
Emara, L. H., Badr, M., & El-Bary, A. A. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120005625 · Cited by 106
Direct Formation of Nanospheres from Amphiphilic β-Cyclodextrin Inclusion Complexes
Memiṣoǧlu, E., Bochot, A., Özalp, M., Şen, M., Duchêne, D., & Hıncal, A. A. (2003) · Pharmaceutical Research · doi:10.1023/a:1022263111961 · Cited by 101
Järvinen, T., Järvinen, K., Schwarting, N., & Stella, V. J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840306 · Cited by 96
Évrard, B., Chiap, P., DeTullio, P., Ghalmi, F., Piel, G., Hees, T. J. V., Crommen, J., Losson, B., & Delattre, L. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00270-5 · Cited by 96
When can cyclodextrins be considered for solubilization purposes?
Rao, V. M., & Stella, V. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10341 · Cited by 93
Improvement of the Oral Bioavailability of Digitalis Glycosides by CyclodextrinComplexation
Uekama, K., FUJINAGA, T., Hirayama, F., Otagiri, M., Yamasaki, M., Seo, H., Hashimoto, T., & Tsuruoka, M. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721125 · Cited by 90
The BCS: Where Do We Go from Here?
Dressman, J., Butler, J., Hempenstall, J., & Reppas, C. I. (2001) · Pharmaceutical technology · Cited by 89
Savolainen, J., Järvinen, K., Taipale, H., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011900527021 · Cited by 88
Arima, H., Yunomae, K., Hirayama, F., et al. (2001) · PubMed · Cited by 85
Kamada, M., Hirayama, F., Udo, K., et al. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00171-2 · Cited by 85
Yunomae, K., Arima, H., Hirayama, F., & Uekama, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00059-0 · Cited by 84
Inclusion complexation of ziprasidone mesylate with β-cyclodextrin sulfobutyl ether
Kim, Y., Oksanen, D. A., Massefski, W. W., Blake, J. F., Duffy, E. M., & Chrunyk, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980109t · Cited by 80
Practical considerations in development of solid dosage forms that contain cyclodextrin
Miller, L. A., Carrier, R. L., & Ahmed, I. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20831 · Cited by 77
Self-citationEnzymic degradation of .alpha.- and .beta.-cyclodextrins by Bacteroides of the human colon
Antenucci, R. N., & Palmer, J. K. (1984) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00126a025 · Cited by 76
Interactions of Griseofulvin with Cyclodextrins in Solid Binary Systems
Veiga, M.-D., Díaz, P. J., & Ahsan, F. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970233x · Cited by 76
Enhancement of Bioavailability of Griseofulvin by Its Complexation with β-Cyclodextrin
Dhanaraju, M. D., Kumaran, K. S., Baskaran, T., & Moorthy, M. S. R. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809085663 · Cited by 76
Rao, V. M., Haslam, J. L., & Stella, V. J. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1034 · Cited by 76
Okimoto, K., Miyake, M., Ohnishi, N., Rajewski, R. A., Stella, V. J., Irie, T., & Uekama, K. (1998) · Pharmaceutical Research · doi:10.1023/a:1011955117026 · Cited by 73
Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes
Veiga, F., Fernandes, C., & Teixeira, F. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00445-2 · Cited by 62
Indomethacin and cyclodextrin complexes
Lin, S.-Z., Wouessidjewe, D., Poelman, M.-C., & Duchêne, D. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90363-s · Cited by 61
Terfenadine–β-Cyclodextrin Inclusion Complex with Antihistaminic Activity Enhancement
Choi, H.-G., Lee, B.-J., Han, J. H., Lee, M., Park, K.-M., Yong, C. S., Rhee, J.-D., Kim, Y.-B., & Kim, C. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100107250 · Cited by 59
Quaglia, F., Varricchio, G., Miro, A., Rotonda, M. I. L., Larobina, D., & Mensitieri, G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00242-5 · Cited by 58
The utilization of Schardinger dextrins by the rat
Andersen, G. H., Robbins, F. M., Domingues, F. J., Moores, R. G., & Long, C. L. (1963) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(63)90048-6 · Cited by 57
Tokumura, T., Tsushima, Y., Kayano, M., Machida, Y., & Nagai, T. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740428 · Cited by 54
Cyclodextrins — Useful excipients for oral peptide administration?
Haeberlin, B., Gengenbacher, T., Meinzer, A., & Fricker, G. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04499-7 · Cited by 52
Tokumura, T., Nanbas, M., Tsushima, Y., Tatsuishi, K., Kayano, M., Machida, Y., & Nagai, T. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750415 · Cited by 51
Soliman, O. A.-E., Kimura, K., Hirayama, F., et al. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04862-4 · Cited by 48
Okimoto, K., Ohike, A., Ibuki, R., et al. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00077-2 · Cited by 45
Ueda, H., Ou, D., Endo, T., Nagase, H., Tomono, K., & NAGAI, T. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809088532 · Cited by 43
Uekama, K., Horikawa, T., Yamanaka, M., & Hirayama, F. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03889.x · Cited by 41
Sangalli, M. E., Zema, L., Maroni, A., Foppoli, A., Giordano, F., & Gazzaniga, A. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00005-9 · Cited by 39
Osmotic Properties of Sulfobutylether and Hydroxypropyl Cyclodextrins
Zannou, E. A., Streng, W. H., & Stella, V. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1010947631380 · Cited by 37
MASAHIKO, K., FUMITOSHI, H., & KANETO, U. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90114-1 · Cited by 35
Interaction of Antimalarial Agent Artemisinin with Cyclodextrins
Usuda, M., Endo, T., Nagase, H., et al. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100101276 · Cited by 34
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Pharmaceutical applications of cyclodextrins: basic science and product development
Loftsson, T., & Brewster, M. E. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01030.x · Cited by 1,031
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Cyclodextrin-based supramolecular systems for drug delivery: Recent progress and future perspective
Zhang, J., & Ma, P. X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.001 · Cited by 836
Drug delivery by supramolecular design
Webber, M. J., & Langer, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00391a · Cited by 814
Metadata
- Authors
- Carrier, R. L., Miller, L. A., & Ahmed, I.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 123
- Issue
- 2
- Pages
- 78-99
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1966132354
- Cited by
- 557
- References
- 61
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.